Secondary outcomes analyzed were neonatal mortality, serum/plasma hemoglobin (g/L), preterm births, iron‐deficiency (ferritin), infant mortality, serum/plasma transferrin receptor (mg/L) and serum/plasma ferritin (ug/L) (3) For MMN vs IFA: primary outcomes analyzed were low birth weight, maternal anaemia and perinatal mortality. This evidence concerns the gene TFRC and anemia.